Sensei Biotherapeutics, Inc.
SNSE
$12.63
-$0.37-2.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 490.70% | -48.75% | -46.72% | -45.25% | -40.89% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.92% | -51.27% | -51.18% | -45.27% | -51.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.68% | -23.33% | 206.17% | -18.31% | 63.57% |
| Total Current Assets | 472.37% | -48.71% | -46.39% | -45.18% | -40.76% |
|
|
|||||
| Total Current Assets | 472.37% | -48.71% | -46.39% | -45.18% | -40.76% |
| Net Property, Plant & Equipment | -61.75% | -59.31% | -64.77% | -62.08% | -59.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 595.83% | -62.50% | -79.31% | -72.41% | -72.09% |
| Total Assets | 436.62% | -49.51% | -48.19% | -46.85% | -42.61% |
|
|
|||||
| Total Accounts Payable | 846.81% | 182.38% | -81.74% | -78.68% | -81.95% |
| Total Accrued Expenses | 265.04% | -25.43% | 63.41% | 74.41% | 411.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -51.70% | -37.45% | -22.97% | -20.04% | -13.20% |
| Total Finance Division Other Current Liabilities | 54.55% | -50.96% | -- | -- | -- |
| Total Other Current Liabilities | 54.55% | -50.96% | -- | -- | -- |
| Total Current Liabilities | 171.37% | -21.97% | -18.47% | -21.74% | 4.75% |
|
|
|||||
| Total Current Liabilities | 171.37% | -21.97% | -18.47% | -21.74% | 4.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -96.14% | -92.82% | -77.00% | -66.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5,351.27% | -38.21% | -38.70% | -41.25% | -23.54% |
|
|
|||||
| Common Stock & APIC | 5.05% | 0.43% | 0.46% | 0.62% | 0.81% |
| Retained Earnings | -68.59% | -8.05% | -9.49% | -10.86% | -12.10% |
| Treasury Stock & Other | -300.00% | 107.69% | -121.43% | 88.17% | 95.62% |
| Total Common Equity | -529.19% | -51.57% | -49.74% | -47.67% | -45.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -529.19% | -51.57% | -49.74% | -47.67% | -45.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -529.19% | -51.57% | -49.74% | -47.67% | -45.30% |
|
|
|||||